Large Molecule Patents

Lucentis is a drug owned by Genentech, Inc.. It is protect by 8 US patents. Given below is the list of those patents along with their expiration dates.

Patent Number Company Patent Title Patent Expiry Activity Alert
US10112994 GENENTECH, INC. Methods of producing two chain proteins in bacteria
Nov, 2035

(11 years from now)

Active
US9765379 GENENTECH, INC. Harvest operations for recombinant proteins
Mar, 2034

(9 years from now)

Active
US10421984 GENENTECH, INC. Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele
Sep, 2033

(8 years from now)

Active
US8383773 GENENTECH, INC. Protein product and method for reducing biomass-biomass interactions
Dec, 2023

(9 months ago)

Expired
US6921659 GENENTECH, INC. Protease-deficient cells
Oct, 2023

(11 months ago)

Expired
US9688775 GENENTECH, INC. System for antibody expression and assembly
Dec, 2022

(1 year, 9 months ago)

Expired
US6828121 GENENTECH, INC. Bacterial host strains
Jul, 2022

(2 years ago)

Expired
US6716602 GENENTECH, INC. Metabolic rate shifts in fermentations expressing recombinant proteins
Nov, 2021

(2 years ago)

Expired


Lucentis's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List


About Lucentis

Active Ingredients:

Lucentis contains Ranibizumab as an active ingredient

Approval Date:

Lucentis was first approved for market use on 30 Jun, 2006.

Dosage:

Lucentis is available in 2 strengths and the following dosage forms are - Injection form for Intravitreal use, Injection form for Intravitreal use.

Strength Dosage Form Availability Application Pathway
10MG/ML (0.5MG/0.05ML) Injection Rx Intravitreal
6MG/ML (0.3MG/0.05ML) Injection Rx Intravitreal
6MG/ML (0.3MG/0.05ML) Injection Rx Intravitreal
6MG/ML (0.3MG/0.05ML) Injection Rx Intravitreal
10MG/ML (0.5MG/0.05ML) Injection Rx Intravitreal
10MG/ML (0.5MG/0.05ML) Injection Rx Intravitreal
10MG/ML (0.5MG/0.05ML) Injection Rx Intravitreal
6MG/ML (0.3MG/0.05ML) Injection Rx Intravitreal